SPARC: A phase-I trial of pre-operative margin-intensified stereotactic radiotherapy for pancreatic cancer at high risk of positive resection margins by Holyoake, D, Robinson, M, Strauss, V, Reilly, G, McIntosh, D, Grose, D

Analysis of on-trial quality assurance for the SPARC clinical trial using novel peer-review methodology by Holyoake, D, Robinson, M, Grose, D, McIntosh, D, Radhakrishna, G, Sebag-Montefiore, D, Hawkins, M

Conformity analysis of target-volume definition for margin-directed boost in pancreatic cancer SBRT by Holyoake, D, Robinson, M, Grose, D, McIntosh, D, Sebag-Montefiore, D, Radhakrishna, G, Patel, N, Mukherjee, S, Hawkins, M

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer. by Holyoake, D, Robinson, M, Grose, D, McIntosh, D, Sebag-Montefiore, D, Radhakrishna, G, Patel, N, Partridge, M, Mukherjee, S, Hawkins, M

Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons. by Tate, S, Benn, S, Hick, C, Trezise, D, John, V, Mannion, R, Costigan, M, Plumpton, C, Grose, D, Gladwell, Z, Kendall, G, Dale, K, Bountra, C, Woolf, C

A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol. by Holyoake, D, Ward, E, Grose, D, McIntosh, D, Sebag-Montefiore, D, Radhakrishna, G, Patel, N, Silva, M, Mukherjee, S, Strauss, V, Odondi, L, Fokas, E, Melcher, A, Hawkins, M